CBIO
Crescent Biopharma, Inc.Company with tickers: CBIO
CIK
1253689
CUSIP
G2545C104
Shares Outstanding
27,571,935
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,039,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $25,768,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Research & Development | $17,903,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Operating Income | $-24,729,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Net Income | $-23,283,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |